Trial Profile

Phase I/IIa trial of autologous tumor vaccine and temozolomide administration in patients with primary glioblastoma.

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 28 Mar 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Autologous formalin-fixed tumour cell vaccine (Primary) ; Temozolomide
Indications Glioblastoma
Focus Therapeutic Use

Most Recent Events

16 Nov 2011 Planned end date changed from 1 Sep 2012 to 1 Sep 2013 as reported by University Hospital Medical Information Network - Japan.
30 Oct 2009 Additional lead trial investigator identified as reported by University Hospital Medical Information Network - Japan.
03 Nov 2008 New trial record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com